Substance P receptor expression in intestinal epithelium in clostridium difficile toxin A enteritis in rats. 1998

C Pothoulakis, and I Castagliuolo, and S E Leeman, and C C Wang, and H Li, and B J Hoffman, and E Mezey
Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

We previously reported that the inflammatory effects of Clostridium difficile toxin A on rat intestine can be significantly inhibited with a specific neurokinin-1 receptor (NK-1R) antagonist. In this study we investigated the localization and expression of NK-1R mRNA and protein in rat intestine by in situ hybridization, Northern blot analysis, and immunohistochemistry, respectively, after exposure to toxin A. Northern blot analysis showed increased mucosal levels of NK-1R mRNA starting 30 min after toxin A administration. In situ hybridization showed that toxin A increased NK-1R mRNA expression in intestinal epithelial cells after 30, 120, and 180 min. In rats pretreated with the NK-1R antagonist CP-96345 the increase in NK-1R mRNA levels after exposure to toxin A was inhibited, indicating that NK-1R upregulation is substance P (SP) dependent. One hour after exposure to toxin A many of the intestinal epithelial cells showed staining for NK-1R compared with controls. Specific 125I-SP binding to purified epithelial cell membranes obtained from ileum exposed to toxin A for 15 min was increased twofold over control and persisted for 4 h. This report provides evidence that NK-1R expression is increased in the intestinal epithelium shortly after exposure to toxin A and may be important in toxin A-induced inflammation.

UI MeSH Term Description Entries
D007082 Ileum The distal and narrowest portion of the SMALL INTESTINE, between the JEJUNUM and the ILEOCECAL VALVE of the LARGE INTESTINE.
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D004751 Enteritis Inflammation of any segment of the SMALL INTESTINE. Enteritides
D004768 Enterotoxins Substances that are toxic to the intestinal tract causing vomiting, diarrhea, etc.; most common enterotoxins are produced by bacteria. Staphylococcal Enterotoxin,Enterotoxin,Staphylococcal Enterotoxins,Enterotoxin, Staphylococcal,Enterotoxins, Staphylococcal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001427 Bacterial Toxins Toxic substances formed in or elaborated by bacteria; they are usually proteins with high molecular weight and antigenicity; some are used as antibiotics and some to skin test for the presence of or susceptibility to certain diseases. Bacterial Toxin,Toxins, Bacterial,Toxin, Bacterial
D001713 Biphenyl Compounds Whitish aromatic crystalline organic compounds made up of two conjoined BENZENE rings. Compounds, Biphenyl
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

C Pothoulakis, and I Castagliuolo, and S E Leeman, and C C Wang, and H Li, and B J Hoffman, and E Mezey
October 2000, Neuroscience letters,
C Pothoulakis, and I Castagliuolo, and S E Leeman, and C C Wang, and H Li, and B J Hoffman, and E Mezey
September 2001, Peptides,
C Pothoulakis, and I Castagliuolo, and S E Leeman, and C C Wang, and H Li, and B J Hoffman, and E Mezey
March 2003, Gastroenterology,
C Pothoulakis, and I Castagliuolo, and S E Leeman, and C C Wang, and H Li, and B J Hoffman, and E Mezey
March 1994, The Journal of clinical investigation,
C Pothoulakis, and I Castagliuolo, and S E Leeman, and C C Wang, and H Li, and B J Hoffman, and E Mezey
April 2008, Digestive diseases and sciences,
C Pothoulakis, and I Castagliuolo, and S E Leeman, and C C Wang, and H Li, and B J Hoffman, and E Mezey
October 2011, Gastroenterologia y hepatologia,
C Pothoulakis, and I Castagliuolo, and S E Leeman, and C C Wang, and H Li, and B J Hoffman, and E Mezey
June 2007, Gastroenterology,
C Pothoulakis, and I Castagliuolo, and S E Leeman, and C C Wang, and H Li, and B J Hoffman, and E Mezey
March 2004, Journal of immunology (Baltimore, Md. : 1950),
C Pothoulakis, and I Castagliuolo, and S E Leeman, and C C Wang, and H Li, and B J Hoffman, and E Mezey
February 2011, Infection and immunity,
C Pothoulakis, and I Castagliuolo, and S E Leeman, and C C Wang, and H Li, and B J Hoffman, and E Mezey
August 2014, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!